Maine Rx Prior Authorization Penalty Violates Federal Medicaid Law - PhRMA
Executive Summary
Imposing prior authorization requirements in Medicaid on drugs from manufacturers that do not participate in the Maine Rx program violates federal law, the Pharmaceutical Research & Manufacturers of America maintains in a lawsuit against that state.
You may also be interested in...
Maine Signs Rx Rebate Deals With 10 Small Firms; SB Stops Shipping To State
Maine has completed drug discount agreements with 10 small pharmaceutical companies as part of the development of its Maine Rx rebate program.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials